financetom
Business
financetom
/
Business
/
Cytokinetics Insider Sold Shares Worth $405,420, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cytokinetics Insider Sold Shares Worth $405,420, According to a Recent SEC Filing
Oct 6, 2025 1:54 PM

04:32 PM EDT, 10/06/2025 (MT Newswires) -- Edward M. Kaye, Director, on October 06, 2025, sold 6,757 shares in Cytokinetics ( CYTK ) for $405,420. Following the Form 4 filing with the SEC, Kaye has control over a total of 9,778 common shares of the company, with 9,778 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000106198325000008/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved